CEBP CTRC-AACR San Antonio Breast Cancer Symposium Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ellsworth, R. E.
Right arrow Articles by Shriver, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ellsworth, R. E.
Right arrow Articles by Shriver, C. D.
Cancer Epidemiology Biomarkers & Prevention Vol. 12, 915-919, September 2003
© 2003 American Association for Cancer Research


Short Communications

High-Throughput Loss of Heterozygosity Mapping in 26 Commonly Deleted Regions in Breast Cancer1

Rachel E. Ellsworth2, Darrell L. Ellsworth, Susan M. Lubert, Jeff Hooke, Richard I. Somiari and Craig D. Shriver

Clinical Breast Care Project, Windber Research Institute, Windber, Pennsylvania 15963 [R. E. E., D. L. E., S. M. L., R. I. S.], and Clinical Breast Care Project, Walter Reed Army Medical Center, Washington, D.C. 20307 [J. H., C. D. S.]

Capillary array electrophoresis and laser-assisted microdissection, which provide increased speed and accuracy in loss of heterozygosity studies, are often used independently in studying breast cancer; the successful coupling of these emerging technologies, however, must overcome technical problems, especially those related to the poor quality and quality of DNA typically retrieved from archival tumor samples. Here we present a panel of 52 microsatellite markers from 26 of the most commonly deleted regions in breast cancer. All markers have been optimized to robustly amplify DNA extracted from paraffin-embedded samples, represent informative (highly polymorphic) loci, and effectively detect chromosomal loss. In the 10 tumor samples (stage 0 to stage III) tested here, chromosomal loss was detected loss for every locus, and the degree of loss at the 26 commonly deleted regions ranged from 23% to 77%. This panel can be used to quickly detect genomic patterns of loss in large numbers of breast tumor samples and may provide both clinical information and molecular information regarding the underlying tumor suppressor genes.




This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
W. F. Symmans and G. N. Hortobagyi
Fingerprinting Lymph Node Metastases
Ann. Surg. Oncol., May 1, 2008; 15(5): 1275 - 1276.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. E. Becker, R. E. Ellsworth, B. Deyarmin, H. L. Patney, R. M. Jordan, J. A. Hooke, C. D. Shriver, and D. L. Ellsworth
The Genomic Heritage of Lymph Node Metastases: Implications for Clinical Management of Patients with Breast Cancer
Ann. Surg. Oncol., April 1, 2008; 15(4): 1056 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. E. Ellsworth, D. L. Ellsworth, B. Love, H. L. Patney, L. R. Hoffman, J. Kane, J. A. Hooke, and C. D. Shriver
Correlation of Levels and Patterns of Genomic Instability With Histological Grading of DCIS
Ann. Surg. Oncol., November 1, 2007; 14(11): 3070 - 3077.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
K. A. Callaghan, T. E. Becker, D. L. Ellsworth, J. A. Hooke, R. E. Ellsworth, and C. D. Shriver
Genomic Instability and the Development of Metastatic Lymph Node Tumors
Ann. Surg. Oncol., November 1, 2007; 14(11): 3125 - 3132.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. E. Ellsworth, D. L. Ellsworth, B. Deyarmin, L. R. Hoffman, B. Love, J. A. Hooke, and C. D. Shriver
Timing of Critical Genetic Changes in Human Breast Disease
Ann. Surg. Oncol., December 1, 2005; 12(12): 1054 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
R. E. Ellsworth, D. L. Ellsworth, D. M. Neatrour, B. Deyarmin, S. M. Lubert, M. J. Sarachine, P. Brown, J. A. Hooke, and C. D. Shriver
Allelic Imbalance in Primary Breast Carcinomas and Metastatic Tumors of the Axillary Lymph Nodes
Mol. Cancer Res., February 1, 2005; 3(2): 71 - 77.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. L. Ellsworth, R. E. Ellsworth, B. Love, B. Deyarmin, S. M. Lubert, V. Mittal, J. A. Hooke, and C. D. Shriver
Outer Breast Quadrants Demonstrate Increased Levels of Genomic Instability
Ann. Surg. Oncol., September 1, 2004; 11(9): 861 - 868.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2003 by the American Association for Cancer Research.